Strategies for treating lipids for prevention: Risk stratification models with and without imaging

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 28, Issue 3, 2014, Pages 295-307

  Okwuosa, Tochi M ^a   Mallikethi Reddy, Sagar ^a   Lloyd Jones, Donald M ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

cardiovascular disease; cholesterol; coronary heart disease; imaging; lipid; novel marker; risk assessment

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ACCH AHA POOLED COHORT EQUATION; ANGINA PECTORIS; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ASSIGN SCORE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD VESSEL PARAMETERS; CARDIAC IMAGING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY CALCIUM SCORE; COST EFFECTIVENESS ANALYSIS; FLOW MEDIATED DILATION; FRAMINGHAM RISK SCORE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LOW RISK POPULATION; META ANALYSIS (TOPIC); NONHUMAN; PREDICTION; PRIMARY PREVENTION; PROCAM SCORE; QRISK SCORE; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REYNOLDS RISK SCORE; RISK ASSESSMENT; RISK MANAGEMENT; RISK REDUCTION; SCORING SYSTEM; SECONDARY PREVENTION; SYSTEMATIC CORONARY RISK EVALUATION; SYSTEMATIC REVIEW (TOPIC); TRANSIENT ISCHEMIC ATTACK; UNITED STATES; WORLD HEALTH ORGANIZATION; ALGORITHM; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIAGNOSTIC IMAGING; DYSLIPIDEMIAS; PROCEDURES; STATISTICAL MODEL;

ALGORITHMS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; DYSLIPIDEMIAS; HUMANS; LIPIDS; MODELS, STATISTICAL; RISK ASSESSMENT;

EID: 84901354321     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2014.01.004     Document Type: Review

References (72)

1. R.J. Myerburg, K.M. Kessler, and A. Castellanos Sudden cardiac death: epidemiology, transient risk, and intervention assessment Ann Intern Med 119 1993 1187 1197
2. A.R. Folsom Classical and novel biomarkers for cardiovascular risk prediction in the United States J Epidemiol - Jpn Epidemiol Assoc 23 2013 158 162
3. D.M. Lloyd-Jones Cardiovascular risk prediction: basic concepts, current status, and future directions Circulation 121 2010 1768 1777
4. P.W. Wilson, R.B. D'Agostino, and D. Levy et al. Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
5. M.T. Cooney, A.L. Dudina, and I.M. Graham Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians J Am Coll Cardiol 54 2009 1209 1227
6. T.J. Wang Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction Circulation 123 2011 551 565
7. J.D. Brunzell, M. Davidson, and C.D. Furberg et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation J Am Coll Cardiol 51 2008 1512 1524
8. S. Nicholls, and P. Lundman The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol Seminars Vasc Med 4 2004 187 195
9. P.S. Jellinger, D.A. Smith, and A.E. Mehta et al. American association of clinical endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis Endocr Pract - Off J Am College Endocrinol Am Assoc Clin Endocrinol 18 Suppl. 1 2012 1 78
10. S.H. Wild, C.D. Byrne, and I. Tzoulaki et al. Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: the Edinburgh Artery Study Atherosclerosis 203 2009 604 609
11. S.M. Rodriguez-Colon, J. Mo, and Y. Duan et al. Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study Stroke - J Cereb Circul 40 2009 200 205
12. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
13. P.M. Ridker, E. Danielson, and F.A. Fonseca et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
14. B. Mihaylova, J. Emberson, and L. Blackwell et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials Lancet 380 2012 581 590
15. F. Taylor, M.D. Huffman, and A.F. Macedo et al. Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev 1 2013 CD004816
16. N.J. Stone, J. Robinson, and A.H. Lichtenstein et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American heart association task force on practice guidelines Circulation 2013 Nov 12. [Epub ahead of print]
17. P. Greenland, J.S. Alpert, and G.A. Beller et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 122 2010 e584 e636
18. R.B. D'Agostino Sr., R.S. Vasan, and M.J. Pencina et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
19. Third report of the National cholesterol Education Program (NCEP) expert panel on Detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report Circulation 106 2002 3143 3421
20. S.M. Grundy, J.I. Cleeman, and C.N. Merz et al. Implications of recent clinical trials for the National cholesterol Education Program adult treatment panel III guidelines Circulation 110 2004 227 239
21. M.T. Cooney, A. Dudina, and R. D'Agostino et al. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation 122 2010 300 310
22. D.C. Goff Jr., D.M. Lloyd-Jones, and G. Bennett et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American heart association task force on practice guidelines Circulation 2013 Nov 12. [Epub ahead of print]
23. R.M. Conroy, K. Pyorala, and A.P. Fitzgerald et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 2003 987 1003
24. J.S. Berger, C.O. Jordan, and D. Lloyd-Jones et al. Screening for cardiovascular risk in asymptomatic patients J Am Coll Cardiol 55 2010 1169 1177
25. A.A. van der Heijden, M.M. Ortegon, and L.W. Niessen et al. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: the Hoorn Study Diabetes Care 32 2009 2094 2098
26. M. Woodward, P. Brindle, and H. Tunstall-Pedoe Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) Heart 93 2007 172 176
27. B. de la Iglesia, J.F. Potter, and N.R. Poulter et al. Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice Heart 97 2011 491 499
28. M. Woodward, H. Tunstall-Pedoe, and A. Rumley et al. Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study Br J Haematol 146 2009 442 446
29. J. Hippisley-Cox, C. Coupland, and Y. Vinogradova et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study BMJ 335 2007 136
30. J. Hippisley-Cox, C. Coupland, and Y. Vinogradova et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 BMJ 336 2008 1475 1482
31. G.S. Collins, and D.G. Altman An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study BMJ 340 2010 c2442
32. J. Hippisley-Cox, C. Coupland, and Y. Vinogradova et al. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study Heart 94 2008 34 39
33. P.M. Ridker, J.E. Buring, and N. Rifai et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score JAMA - J Am Med Assoc 297 2007 611 619
34. P.M. Ridker, N.P. Paynter, and N. Rifai et al. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men Circulation 118 2008 2243 2251 4p. following 2251
35. N.R. Cook, N.P. Paynter, and C.B. Eaton et al. Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative Circulation 125 2012 1748 1756 S1-S11
36. D.M. Lloyd-Jones, E.P. Leip, and M.G. Larson et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 2006 791 798
37. J.D. Berry, K. Liu, and A.R. Folsom et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis Circulation 119 2009 382 389
38. P.K. Shah Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol 56 2010 98 105
39. P. Greenland, R.O. Bonow, and B.H. Brundage et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) Circulation 115 2007 402 426
40. R. Detrano, A.D. Guerci, and J.J. Carr et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups N Engl J Med 358 2008 1336 1345
41. R. Erbel, S. Mohlenkamp, and S. Moebus et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study J Am Coll Cardiol 56 2010 1397 1406
42. S.A. Peters, H.M. den Ruijter, and M.L. Bots et al. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review Heart 98 2012 177 184
43. D.C. Goff Jr., A.G. Bertoni, and H. Kramer et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium Circulation 113 2006 647 656
44. J. Yeboah, R.L. McClelland, and T.S. Polonsky et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals JAMA - J Am Med Assoc 308 2012 788 795
45. J.A. Rumberger, D.B. Simons, and L.A. Fitzpatrick et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study Circulation 92 1995 2157 2162
46. A.P. Burke, A. Taylor, and A. Farb et al. Coronary calcification: insights from sudden coronary death victims Z Kardiol 89 Suppl. 2 2000 49 53
47. G.T. Kondos, J.A. Hoff, and A. Sevrukov et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults.[see comment] Circulation 107 2003 2571 2576
48. J.E. Manson, J. Hsia, and K.C. Johnson et al. Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
49. A.J. Taylor, J. Bindeman, and I. Feuerstein et al. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project J Am Coll Cardiol 46 2005 807 814
50. M.L. Daviglus, A. Pirzada, and K. Liu et al. Comparison of low risk and higher risk profiles in middle age to frequency and quantity of coronary artery calcium years later Am J Cardiol 94 2004 367 369
51. P. Greenland, L. LaBree, and S.P. Azen et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.[see comment][erratum appears in JAMA. 2004 Feb 4;291(5):563] J Am Med Assoc 291 2004 210 215
52. S.G. Lakoski, P. Greenland, and N.D. Wong et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA).[see comment] Arch Intern Med 167 2007 2437 2442
53. Y. Arad, K.J. Goodman, and M. Roth et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study J Am Coll Cardiol 46 2005 158 165
54. R. Tota-Maharaj, M.J. Blaha, and J.W. McEvoy et al. Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old Eur Heart J 33 2012 2955 2962
55. T.S. Polonsky, R.L. McClelland, and N.W. Jorgensen et al. Coronary artery calcium score and risk classification for coronary heart disease prediction JAMA - J Am Med Assoc 303 2010 1610 1616
56. R.L. McClelland, H. Chung, and R. Detrano et al. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA) Circulation 113 2006 30 37
57. J. Perk, G. De Backer, and H. Gohlke et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur Heart J 33 2012 1635 1701
58. Z. Reiner, A.L. Catapano, and G. De Backer et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
59. S. Ehara, Y. Kobayashi, and M. Yoshiyama et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study Circulation 110 2004 3424 3429
60. J. Shemesh, S. Apter, and Y. Itzchak et al. Coronary calcification compared in patients with acute versus in those with chronic coronary events by using dual-sector spiral CT Radiology 226 2003 483 488
61. E.S. Houslay, S.J. Cowell, and R.J. Prescott et al. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial Heart 92 2006 1207 1212
62. M.H. Criqui, J.O. Denenberg, and J.H. Ix et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events JAMA 311 3 2014 271 278
63. J.F. Polak, M.J. Pencina, and K.M. Pencina et al. Carotid-wall intima-media thickness and cardiovascular events N Engl J Med 365 2011 213 221
64. V. Nambi, L. Chambless, and A.R. Folsom et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk in Communities) study J Am Coll Cardiol 55 2010 1600 1607
65. H.M. Den Ruijter, S.A. Peters, and T.J. Anderson et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis JAMA - J Am Med Assoc 308 2012 796 803
66. M. Kavousi, S. Elias-Smale, and J.H. Rutten et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study Ann Intern Med 156 2012 438 444
67. M.W. Lorenz, C. Schaefer, and H. Steinmetz et al. Is carotid intima media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the Carotid Atherosclerosis Progression Study (CAPS) Eur Heart J 31 2010 2041 2048
68. F.G. Fowkes, G.D. Murray, and I. Butcher et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis JAMA - J Am Med Assoc 300 2008 197 208
69. J.S. Lin, C.M. Olson, and E.S. Johnson et al. The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. preventive services task force Ann Intern Med 159 2013 333 341
70. J. Yeboah, A.R. Folsom, and G.L. Burke et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis Circulation 120 2009 502 509
71. J. Yeboah, J.R. Crouse, and F.C. Hsu et al. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study Circulation 115 2007 2390 2397
72. Y. Inaba, J.A. Chen, and S.R. Bergmann Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis Int J Cardiovasc Imaging 26 2010 631 640